DOI QR코드

DOI QR Code

Effect of yoghurt with a Bifidobacteria enhancer and dietary fiber on irritable bowel syndrome

  • Cho, Young Hoon (Institute of Research Namyang Dairy Products Co., Ltd.) ;
  • Bae, Hyoung Churl (Department of Animal Biosystem Science, College of Agriculture and Life Sciences, Chungnam National University) ;
  • Nam, Myoung Soo (Department of Animal Biosystem Science, College of Agriculture and Life Sciences, Chungnam National University)
  • Received : 2021.06.15
  • Accepted : 2021.07.22
  • Published : 2021.09.01

Abstract

This study was carried out to investigate the effects of supplementation with a Bifidobacteria enhanced yogurt (BE0623 yogurt), which includes Bifidobacterium lactis BB12, Lactobacillus acidophilus, Streptococcus thermophilus, and Bifidobacterium lactis, in the management of irritable bowel syndrome (IBS) using animal models and clinical trials. In a rat study, a loperamide-treated group (LOP) showed reduced water content in fecal pellets but showed an increased number of fecal pellets in the distal colon. In addition, the BE0623 yogurt (L-BE0623Y) group had the fewest fecal pellets in the distal colon. Regarding the serum lipid parameters, the LOP group had a high-density lipoprotein (HDL)/total cholesterol ratio that was 43% lower than that of a normal water group (NOR), but the outcome for the L-BE0623Y group was 27% lower than the NOR group. In a human study, 116 adults with IBS were sampled as subjects and fed 300 mL of yogurt per day for an eight week period. There was an IBS improvement in the L-BE0623Y and commercial yogurt (L-CY) groups, though flatulence, stool consistency and frequency of defecation outcomes were also noted. Specifically, the L-BE0623Y treatment group showed significant effects with regard to defecation duration and urgency after the consumption of the yogurt used in this study. These results suggest that the Bifidobacteria-enhanced yogurt has superior effects with regard to relieving loperamide-induced constipation in rats and that regular consumption of L-BE0623Y is effective to improve IBS in humans.

Keywords

References

  1. Barbara G, De Giorgio R, Stanghellini V, Cremon C, Salvioli B, Corinaldesi R. 2004. New pathophysiological mechanisms in irritable bowel syndrome. Alimentary Pharmacology and Therapeutics 20(suppl 2):1-9.
  2. Blanchard EB, Lackner JM, Jaccard J, Rowell D, Carosella AM, Powell C, Sanders K, Krasner S, Kuhn E. 2008. The role of stress in symptom exacerbation among IBS patients. Journal of Psychosomatic Research 64:119-128. https://doi.org/10.1016/j.jpsychores.2007.10.010
  3. Brandt LJ, Chey WD, Foxx-Orenstein AE, Schiller LR, Schoenfeld PS, Spiegel BM, Talley NJ, Quigley EM. 2009. American college of gastroenterology task force on irritable bowel syndrome. An evidence-based position statement on the management of irritable bowel syndrome. The American Journal of Gastroenterology 104(suppl 1):S1-S35.
  4. Cann PA, Read NW, Holdsworth CD, Barends D. 1984. Role of loperamide and placebo in management of irritable bowel syndrome (IBS). Digestive Diseases and Sciences 29:239-247. https://doi.org/10.1007/BF01296258
  5. Cho YH, Nam MS. 2021. Characteristics of fermented milk containing Bifidobacterium growth promoter (BE0623) and dietary fiber. Korean Journal of Agricultural Science 48:209-218. [in Korean] https://doi.org/10.7744/KJOAS.210014
  6. Cho YH, Shim JY, Nam MS. 2020. Properties of BE0623 to serve as a growth factor of Bifidobacterium. Korean Journal of Agricultural Science 47:445-457. [in Korean] https://doi.org/10.7744/KJOAS.20200034
  7. Cho YS, Kim SI, Han YS. 2008. The quality characteristics of slander glasswort yogurt and its effect on the relief from constipation. Korean Journal of Food and Cookery Science 24:212-221. [in Korean]
  8. Dimsdale JE, Herd JA, Hartley LH. 1983. Epinephrine mediated increases in plasma cholesterol. Psychosomatic Medicine 45:227-232. https://doi.org/10.1097/00006842-198306000-00005
  9. Eswaran S, Tack J, Chey WD. 2011. Food: The forgotten factor in the irritable bowel syndrome. Gastroenterology Clinics of North America 40:141-162. https://doi.org/10.1016/j.gtc.2010.12.012
  10. Farombi EO, Nwankow JO, Emerole GO. 1997. Possible modulatory effect of browned yam flour diet on chemically-induced toxicity in the rat. Food and Chemical Toxicology 35:975-979. https://doi.org/10.1016/S0278-6915(97)87266-3
  11. Frankenhaeuser M. 1971. Behavior and circulating catecholamines. Brain Research 31:241-262. https://doi.org/10.1016/0006-8993(71)90180-6
  12. Freyschuss U, Hjemdahl PAJD, Linde B. 1986. Cardiovascular and metabolic responses to low dose epinephrine infusion: An invasive study in humans. Clinical Science 70:199-206. https://doi.org/10.1042/cs0700199
  13. Hjemdahl P, Linde B. 1983. Influence of circulating NE and Epi on adipose tissue, vascular resistance and lipolysis in humans. The American Journal of Physiology 245:H447-H452.
  14. Jeon JR, Kim JY, Choi JH. 2007. Effect of yam yogurt on colon mucosal tissue of rats with loperamide-induced constipation. Food Science and Biotechnology 16:605-609.
  15. Khoshoo V, Armstead C, Landry L. 2006. Effect of a laxative with and without tegaserod in adolescents with constipation predominant irritable bowel syndrome. Alimentary Pharmacology and Therapeutics 23:191-196. https://doi.org/10.1111/j.1365-2036.2006.02705.x
  16. Kim DH, Kim JH, Kim CH, You JH, Hwang B, Lee HJ, Kim JD, Lee HY. 2005. Screening of anti-stress activities in extracts from Korean medicinal herbs. Korean Journal of Medicinal Crop Science 13:103-109. [in Korean]
  17. Kim HJ, Kim SI, Han YS. 2008. Effects of sea tangle extract and sea tangle yogurt on constipation relief. Korean Journal of Food and Cookery Science 24:59-67. [in Korean]
  18. Kim JH. 2010. Immune and anti-stress activities of pine needle and the quality characteristics of pine needle yogurt. MS dissertation, Sookmyung Women's Univ., Seoul, Korea.
  19. Lee JJ, Lee YM, Jung SK, Kim KY, Lee MY. 2008. Effects of dietary Mulberry leaf on loperamide-induced constipation in rats. Korean Journal of Food Preservation 15:280-287. [in Korean]
  20. Lee SY, Lee KJ, Kim SJ, Cho SW. 2009. Prevalence and risk factors for overlaps between gastroesophageal reflux disease, dyspepsia, and irritable bowel syndrome: A population-based study. Digestion 79:196-201. https://doi.org/10.1159/000211715
  21. Mayer EA, Tillisch K, Bradesi S. 2006. Review article: Modulation of the brain-gut axis as a therapeutic approach in gastrointestinal disease. Alimentary Pharmacology and Therapeutics 24:919-933. https://doi.org/10.1111/j.1365-2036.2006.03078.x
  22. Monsbakken KW, Vandvik PO, Farup PG. 2006. Perceived food intolerance in subjects with irritable bowel syndrome-etiology, prevalence and consequences. European Journal of Clinical Nutrition 60:667-672. https://doi.org/10.1038/sj.ejcn.1602367
  23. Park M, Camilleri M. 2006. Is there a role of food allergy in irritable bowel syndrome and functional dyspepsia: A systematic review. Neurogastroenterology and Motility 18:595-607. https://doi.org/10.1111/j.1365-2982.2005.00745.x
  24. Park MK, Jin YG, Kim DG, Jin JY, Lee YJ. 2007. Effects of Lentinus edodes extract on the loperamide-induced constipation in rats. Korea Journal of Food Science and Technology 39:88-93. [in Korean]
  25. Rey E, Garcia-Alonso MO, Moreno-Ortega M, Alvarez-Sanchez A, Diaz-Rubio M. 2008. Determinants of quality of life in irritable bowel syndrome. Journal of Clinical Gastroenterology 42:1003-1009. doi: 10.1097/MCG.0b013e31815af9f1.
  26. Schiller LR, Santa Anan CA, Moravski SC, Fordtran JS. 1984. Mechanism of the antidiarrheal effect of loperamide. Gastroenteroly 86:1475-1480. https://doi.org/10.1016/S0016-5085(84)80161-4
  27. Shimotoyodome A, Meguro S, Hase T, Tokimitsu I, Sakata T. 2000. Decreased colonic mucus in rats with loperamide-induced constipation. Comparative Biochemistry and Physiology Part A: Molecular & Integrative Physiology 126:203-212. https://doi.org/10.1016/S1095-6433(00)00194-X
  28. Shin KO, Jeon JR, Lee JS, Kim JY, Lee CH, Kim SD, Yu YS, Nam DH. 2006. Lactic acid fermentation of Chinese yam (Dioscorea batatasDecne) flour and its pharmacological effect on gastrointestinal function in rat model. Biotechnology and Bioprocess Engineering 11:240-244. https://doi.org/10.1007/BF02932037
  29. Sinn DH, Song JH, Kim HJ, Lee JH, Son HJ, Chang DK, Kim YH, Kim JJ, Rhee JC, Rhee PL. 2008. Therapeutic effect of Lactobacillus acidophilus-SDC 2012, 2013 in patients with irritable bowel syndrome. Digestive Diseases and Sciences 53:2714-2718. https://doi.org/10.1007/s10620-007-0196-4
  30. Spiegel BM. 2009. The burden of IBS: Looking at metrics. Current Gastroenterology Reports 11:265-269. https://doi.org/10.1007/s11894-009-0039-x